Enhanced immunity after Ad26.COV2.S vaccine breakthrough infection.
Where this comes from
- Record sourced from PubMed, PMID 35474738.
- Also identified by DOI 10.1016/j.xcrm.2022.100579 and PMC identifier 8922435.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
A study by Kitchin, Richardson et al. finds that breakthrough infection with the SARS-CoV-2 Delta variant in Ad26.COV2.S-vaccinated individuals induces strong neutralizing antibody responses against multiple variants, including the Omicron variant.
Medical subject headings
- COVID-19
- Viral Vaccines